Related Experiment Video
Updated: Jan 11, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Cardiac Channelopathies in the Pediatric Patient: Long QT Syndrome
Christopher W Follansbee1, Andrew P Landstrom2, Peter F Aziz3
1Department of Pediatrics, University of Pittsburgh School of Medicine, Heart and Vascular Institute, UPMC Children's Hospital of Pittsburgh, 5th Floor Faculty Pavilion, 4401 Penn Avenue, Pittsburgh, PA 15224, USA.
Congenital long QT syndrome, an inherited arrhythmia, often affects children, causing dangerous heart rhythms. Early diagnosis and management significantly reduce event risks, enabling most patients to participate in sports.
Area of Science:
- Cardiology
- Genetics
- Pediatrics
Background:
- Congenital long QT syndrome (LQTS) is the most common inherited arrhythmia.
- It is characterized by QT interval prolongation without structural heart disease.
- Manifestations often occur in childhood, leading to arrhythmias or sudden cardiac death.
Purpose of the Study:
- To summarize the key aspects of congenital long QT syndrome.
- To highlight diagnostic approaches and management strategies.
- To discuss the implications for patient quality of life, including sports participation.
Main Methods:
- Review of personal and family history.
- Clinical testing and electrocardiogram (ECG) interpretation.
- Genetic testing for high diagnostic yield.
Main Results:
- Genetic testing is valuable but a negative result does not exclude LQTS.
- Arrhythmia event incidence is reduced with trigger avoidance.
- Appropriate medical therapy is crucial for managing the condition.
Conclusions:
- Congenital LQTS requires thorough diagnosis combining clinical and genetic evaluation.
- Effective management strategies significantly improve patient outcomes.
- Most patients can safely participate in sports with proper care.
Related Concept Videos
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Mechanism of Cardiac Arrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias VI: Management of Dysrhythmias
Cardiomyopathy III: Hypertrophic Cardiomyopathy

